Skip to menu Skip to content Skip to footer

2008

Journal Article

The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptin

Kaisar, Omar M., Johnson, David W., Prins, Judith B. and Isbel, Nicole (2008). The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptin. Current Cardiology Reviews, 4 (4), 287-292. doi: 10.2174/157340308786349516

The role of novel biomarkers of cardiovascular disease in chronic kidney disease: Focus on adiponectin and leptin

2008

Conference Publication

Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing

Percy, Christine, Brown, L., Johnson, D. W. and Gobe, G. (2008). Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing. Australian and New Zealand Society of Nephrology (ANZSN) Annual Conference, Newcastle, Australia, 6-10 September 2008.

Peroxisome proliferator-activated receptors (PPARs) in chronic kidney disease in ageing

2008

Conference Publication

Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

Gobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Carlton, Australia: Blackwell. doi: 10.1111/j.1440-1797.2008.001013.x

Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

2008

Conference Publication

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

Percy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2008). Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. OXFORD: BLACKWELL PUBLISHING.

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

2008

Conference Publication

Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

Gobe, G. C., Yamada, M., Vesey, D. A. and Johnson, D. W. (2008). Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 11th Asian-Pacific Congress of Nephrology, Kuala Lumpur, Malaysia, 5–8 May 2008. Carlton, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x

Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

2008

Conference Publication

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

Gobe, G. C., Vesey, D. A., Bennett, N. C. and Johnson, D. W. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 4-7 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

2008

Conference Publication

Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses

Gobe, Glenda C., Bennett, Nigel, Patel, Jatin, Colditz, Paul, Vesey, David A. and Johnson, David W. (2008). Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses. Renal Week 2008: American Society of Nephrology Annual Meeting, Philadephia, USA, 14 - 19 November, 2008. Washington, D. C., USA: American Society of Nephrology.

Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses

2008

Conference Publication

Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study

Kaisar, Mohd, Armstrong, Kirsten, Hawley, Carmel, Campbell, Scott, Mudge, David, Johnson, David, Prins, John and Isbel, Nicole (2008). Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study. 8th American Transplant Congress, Toronto, Canada, 31 May - 4 June 2008 . Hoboken, NJ, United States: Wiley-Blackwell .

Adiponectin is associated with cardiovascular disease in renal transplant recipients: Baseline results from the LANDMARK 2 study

2008

Journal Article

Pure red cell aplasia induced by erythropoiesis-stimulating agents

Pollock, C., Johnson, D. W., Horl, W., Rossert, J., Casadevall, N., Schellekens, H., Delage, R., De Francisco, A., Macdougall, I., Thorpe, R. and Toffelmire, E. (2008). Pure red cell aplasia induced by erythropoiesis-stimulating agents. Clinical Journal of the American Society of Nephrology, 3 (1), 193-199. doi: 10.2215/CJN.02440607

Pure red cell aplasia induced by erythropoiesis-stimulating agents

2008

Journal Article

The impact of automated eGFR reporting and education on nephrology service referrals

Noble, E, Johnson, DW, Gray, N, Hollett, P, Hawley, CM, Campbell, SB, Mudge, DW and Isbel, NM (2008). The impact of automated eGFR reporting and education on nephrology service referrals. Nephrology, Dialysis, Transplantation, 23 (12), 3845-3850. doi: 10.1093/ndt/gfn385

The impact of automated eGFR reporting and education on nephrology service referrals

2007

Journal Article

Treatment of peritoneal dialysis-associated peritonitis: A systematic review of randomized controlled trials

Wiggins, Kathryn J., Johnson, David W., Craig, Jonathan C. and Strippoli, Giovanni F. M. (2007). Treatment of peritoneal dialysis-associated peritonitis: A systematic review of randomized controlled trials. American Journal of Kidney Diseases, 50 (6), 967-988. doi: 10.1053/j.ajkd.2007.08.015

Treatment of peritoneal dialysis-associated peritonitis: A systematic review of randomized controlled trials

2007

Journal Article

Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway

Li, Jun, Vesey, David A., Johnson, David W. and Gobe, Glenda C. (2007). Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. Cancer Biology Therapy, 6 (12), 1944-1950. doi: 10.4161/cbt.6.12.4975

Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Mollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology.

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

2007

Journal Article

Is the declining use of long-term peritoneal dialysis justified by outcome data?

Khawar, Osman, Kalantar-Zadeh, Kamyar, Lo, Wai Kei, Johnson, David and Mehrotra, Mehrotra, Rajnish (2007). Is the declining use of long-term peritoneal dialysis justified by outcome data?. American Society of Nephrology, 2 (6), 1317-1328. doi: 10.2215/CJN.02550607

Is the declining use of long-term peritoneal dialysis justified by outcome data?

2007

Journal Article

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations (Position paper)

Mathew, Timothy H., Johnson, David W. and Jones, Graham R. D. (2007). Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations (Position paper). Medical Journal of Australia, 187 (8), 459-463. doi: 10.5694/j.1326-5377.2007.tb01357.x

Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations (Position paper)

2007

Journal Article

High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis

Wiggins, Kathryn J., McDonald, Stephen P., Brown, Fiona G., Rosman, Johan B. and Johnson, David W. (2007). High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrology, Dialysis, Transplantation, 22 (10), 3005-3012. doi: 10.1093/ndt/gfm324

High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis

2007

Journal Article

Cardiovascular disease in patients with chronic kidney disease

Kaisar, M., Isbel, N. and Johnson, D. W. (2007). Cardiovascular disease in patients with chronic kidney disease. Minerva Urologica e Nefrologica, 59 (3), 281-297.

Cardiovascular disease in patients with chronic kidney disease

2007

Journal Article

Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation

Vesey, David A., Kruger, Wade A., Poronnik, Philip, Gobe, Glenda C. and Johnson, David W. (2007). Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation. American Journal of Physiology: Renal Physiology, 293 (5), F1441-F1449. doi: 10.1152/ajprenal.00088.2007

Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation

2007

Journal Article

Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levels

Cheung, Catherine W., Taylor, Paul J., Kirkpatrick, Carl M.J., Vesey, David A., Gobe, Glenda C., Winterford, Clay, Nicol, David L. and Johnson, David W. (2007). Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levels. BJU International, 100 (2), 438-444. doi: 10.1111/j.1464-410X.2007.07012.x

Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levels

2007

Journal Article

Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification

Johnson, David W., Armstrong, Kirsten, Campbell, Scott B., Mudge, David W., Hawley, Carmel M., Coombes, Jeff S., Prins, Johannes B. and Isbel, Nicole M. (2007). Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology, 12 (4), 391-398. doi: 10.1111/j.1440-1797.2007.00804.x

Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification